Evidence map›Paper›PMID 35602233›Full record

ArticleCommunications medicine2021

Laura R Marks, Juan J Calix, John A Wildenthal, Meghan A Wallace, Sanjam S Sawhney, Eric M Ransom, Michael J Durkin, Jeffrey P Henderson, Carey-Ann D Burnham, Gautam Dantas

Open access · goldAbstract read
In one paragraph

Article in Communications medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Metabolites · 2025
    Review
  4. Community-Acquired Staphylococcus aureus Bacteremia Among People Who Inject Drugs: A National Cohort Study in England, 2017-2020.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  5. Article
  6. Article
  7. Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Laura R Marks *Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO USA.ORCID 0000-0002-5317-443X
Juan J Calix *Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO USA.ORCID 0000-0003-0424-6721
John A WildenthalDivision of Infectious Diseases, Washington University School of Medicine, St. Louis, MO USA.
Meghan A WallaceDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO USA.
Sanjam S SawhneyThe Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO USA.
Eric M RansomDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO USA.
Michael J DurkinDivision of Infectious Diseases, Washington University School of Medicine, St. Louis, MO USA.
Jeffrey P HendersonDivision of Infectious Diseases, Washington University School of Medicine, St. Louis, MO USA.
Carey-Ann D BurnhamDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO USA.
Gautam DantasThe Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO USA.ORCID 0000-0003-0455-8370
Washington University in St. Louis · US

Funding

NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTISTT32GM007200 · NIGMS · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1985 to 2024
$59.8M
Infectious Diseases/Basic Microbial Pathogenic MechanismsT32AI007172 · NIAID · WASHINGTON UNIVERSITY · PI Daniel E. Goldberg, JENNIFER A PHILIPS · 1985 to 2026
$13.0M
STRUCTURAL, MECHANISTIC, & EVOLUTIONARY CHARACTERIZATION OF TETRACYCLINE DESTRUCTASESU01AI123394 · NIAID · WASHINGTON UNIVERSITY · PI DANTAS, GAUTAM, WENCEWICZ, TIMOTHY ADAM · 2020 to 2025
$4.1M
PHYLOGENOMIC, TRANSCRIPTOMIC, VIROMIC, AND IMMUNOPROTEOMIC DETERMINANTS OF NECROTIZING ENTEROCOLITISR01HD092414 · NICHD · WASHINGTON UNIVERSITY · PI DANTAS, GAUTAM, TARR, PHILLIP I · 2017 to 2021
$3.0M
Metabolomic Signatures of Urologic Chronic Pelvic Pain SyndromeR01DK125860 · NIDDK · WASHINGTON UNIVERSITY · PI HENDERSON, JEFFREY P · 2021 to 2025
$2.8M
Metabolomic Mechanisms of Nutritional Immunity in the Urinary TractR01DK111930 · NIDDK · WASHINGTON UNIVERSITY · PI HENDERSON, JEFFREY P · 2018 to 2021
$1.4M
Defining microbial and host determinants of Acinetobacter survival in the urinary tractK08AI148582 · NIAID · WASHINGTON UNIVERSITY · PI CALIX, JUAN JOSE · 2020 to 2024
$714k
Metabolomic Mechanisms of Nutritional Immunity in the Urinary TractR56DK111930 · NIDDK · WASHINGTON UNIVERSITY · PI HENDERSON, JEFFREY P · 2016 to 2016
$125k
NIAID NIH HHS K08 AI148582NIAID NIH HHS T32 AI007172NIAID NIH HHS U01 AI123394NICHD NIH HHS R01 HD092414NIDDK NIH HHS R01 DK111930NIDDK NIH HHS R01 DK125860NIDDK NIH HHS R56 DK111930NIGMS NIH HHS T32 GM007200
6 · The paper itself

Abstract

Background: The ongoing injection drug use (IDU) crisis in the United States has been complicated by an emerging epidemic of Methods: We performed a case-control study comparing Results: Here we show that patients with IDU-BSI experience longer durations of bacteremia and have lower medical therapy completion rates. In phylogenetic analyses, 45/154 and 1/91 contemporaneous IDU-BSI and non-IDU BSI staphylococcal isolates, respectively, group into multiple, unique clonal clusters, revealing that pathogen community transmission distinctively spurs IDU-BSI. Lastly, multiple Conclusions: We identify clonal expansion of multiple

Indexed as

Bacterial infectionInfectious-disease epidemiology

Identifiers

PMID35602233
PMCPMC9053277
OpenAlexW3216491650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.